Under the gloom of the epidemic, many industries are undergoing closure, but the medical industry has become more lively. On August 2, Siemens Healthineers acquired all shares of Varian Medical Systems, a global leader in the field of cancer medicine, at a price of US$177.50 per share.
Following the Chinese biopharmaceutical company Everest Medicines, which was listed in Hong Kong in early October and raised approximately HKD 3.3 billion, Hong Kong’s IPO market soon ushered in an upstart in the biotech industry. RemeGen, founded in 2008 by Professor Fang Jianmin who graduated from Harvard, has announced its fund-raising plan for listing and is expected to win the throne of this year's largest biotech IPO.
Read full text: